BioPharma-Reporter.com | UCL spin-out aims to smuggle antibodies across the blood-brain barrier BioPharma-Reporter.com A collaboration involving academia and industry is to develop new ways of delivering antibodies to the brain using molecular envelop technology developed by Nanomerics, a UCL spin-out company. |
